Federal Register / Vol. 72, No. 82 / Monday, April 30, 2007 / Notices 21265 

additives, Food additives, Pesticides 

and pests, Reporting and recordkeeping 

requirements. 

Dated: April 18, 2007. 

Janet L. Andersen, 

Director, Biopesticides and Pollution 

Prevention Division, Office of Pesticide 

Programs. 

[FR Doc. E7–8179 Filed 4–27–07; 8:45 am] 

BILLING CODE 6560–50–S 

FEDERAL COMMUNICATIONS 

COMMISSION 

Sunshine Act Meeting Schedule 

Change; Open Commission Meeting, 

April 25, 2007 

April 25, 2007. 

The Federal Communications 

Commission previously announced its 

intention to hold an Open Meeting on 

Wednesday, April 25, 2007 at 9:30 a.m. 

The meeting has been postponed until 

6:45 p.m. The prompt and orderly 

conduct of the Commission’s business 

requires this change and no earlier 

announcement was practicable. 

Federal Communications Commission. 

Marlene H. Dortch, 

Secretary. 

Editorial Note: This document was 

received at the Office of the Federal Register 

on April 26, 2007. 

[FR Doc. 07–2119 Filed 4–26–07; 12:47 pm] 

BILLING CODE 6712–01–P 

FEDERAL ELECTION COMMISSION 

Sunshine Act Meeting Notices 

DATE AND TIME: Thursday, May 3, 2007, 

at 10 a.m. 

PLACE: 999 E Street, NW., Washington, 

DC (Ninth Floor). 

STATUS: This Meeting will be Open to 

the Public. 

ITEMS TO BE DISCUSSED: 

Correction and Approval of Minutes. 

Advisory Opinion 2007–05: Erik Iverson 

by counsel, Donald F. McGahn, II. 

Advisory Opinion 2007–06: Libertarian 

Party of Indiana by Todd Singer, 

Treasurer. 

Notice of Proposed Rulemaking on 

Hybrid Ads. 

Management and Administrative 

Matters. 

PERSON TO CONTACT FOR INFORMATION: 

Mr. Robert Biersack, Press Officer, 

Telephone: (202) 694–1220. 

Mary W. Dove, 

Secretary of the Commission. 

[FR Doc. 07–2138 Filed 4–26–07; 2:57 pm] 

BILLING CODE 6715–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

A Public Health Action Plan To Combat 

Antimicrobial Resistance (Part I: 

Domestic Issues): Meeting for Public 

Comment on the Antimicrobial 

Resistance Interagency Task Force 

Annual Report 

The Centers for Disease Control and 

Prevention (CDC), Food and Drug 

Administration (FDA), and National 

Institutes of Health (NIH) announce an 

open meeting concerning antimicrobial 

resistance. 

Name: A Public Health Action Plan to 

Combat Antimicrobial Resistance (Part I: 

Domestic Issues): Meeting for Public 

Comment on the Antimicrobial 

Resistance Interagency Task Force 

Annual Report. 

Times and Dates: 11:30 a.m.–12:30 

p.m., Wednesday, June 27, 2007. 

Place: Hyatt Regency Bethesda, 

Bethesda, Maryland, One Bethesda 

Metro Center (7400 Wisconsin Ave), 

Bethesda, Maryland, USA 20814; Tel: 1–

301–652–2000; Fax: 1–301–652–4525). 

Status: Open to the public, limited 

only by the space available. 

Purpose: To present the annual report 

of progress by Federal agencies in 

accomplishing activities outlined in A 

Public Health Action Plan to Combat 

Antimicrobial Resistance (Part I: 

Domestic Issues) and solicit comments 

from the public regarding the annual 

report. The Action Plan serves as a 

blueprint for activities of Federal 

agencies to address antimicrobial 

resistance. The focus of the plan is on 

domestic issues. 

Matters To Be Discussed: The agenda 

will consist of welcome and 

introductory comments, an executive 

summary, and brief reports in four focus 

areas: Surveillance, Prevention and 

Control, Research, and Product 

Development. The meeting will then be 

open for general discussion. 

Comments and suggestions from the 

public for Federal agencies related to 

each of the focus areas will be taken 

under advisement by the Antimicrobial 

Resistance Interagency Task Force. The 

agenda does not include development of 

consensus positions, guidelines, or 

discussions or endorsement of specific 

commercial products. 

The Action Plan, Annual Report, and 

meeting agenda are available at http:// 

www.cdc.gov/drugresistance. The public 

meeting is sponsored by the CDC, FDA, 

and NIH in collaboration with seven 

other Federal agencies and departments 

that were involved in developing and 

writing A Public Health Action Plan to 

Combat Antimicrobial Resistance (Part I: 

Domestic Issues). 

Agenda items are subject to change as 

priorities dictate. 

Limited time will be available for oral 

questions, comments, and suggestions 

from the public. Depending on the 

number wishing to comment, a time 

limit of three minutes may be imposed. 

In the interest of time, visual aids will 

not be permitted, although written 

material may be submitted for 

subsequent review by the Task Force. 

Written comments and suggestions from 

the public are encouraged and should be 

received by the contact person or email 

listed below prior to the opening of the 

meeting or no later than the end of July 

2007. 

Persons anticipating attending the 

meeting are requested to send written 

notification to the contact person below 

by June 21, 2007, including name, 

organization (if applicable), address, 

phone, fax, and e-mail address. 

Contact Person for More Information: 

Marsha A. Jones, Office of Antimicrobial 

Resistance, CCID/CDC, Mailstop A–07, 

1600 Clifton Road, NE., Atlanta, GA 

30333; telephone 404–639–4111; fax 

404–639–7444. 

Dated: April 23, 2007. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention (CDC). 

[FR Doc. E7–8158 Filed 4–27–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): 

Epidemiological Studies of Epilepsy, 

Potential Extramural Project 2007–R–

05 

Correction: This notice was published 

in the Federal Register on April 9, 2007, 

Volume 72, Number 67, page 17555. 

The meeting was originally scheduled 

as a teleconference. In lieu of a 


rwilkins on PROD1PC63 with NOTICES